Morocco latest patents query
The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
METHODS AND COMPOSITIONS INTENDED FOR THE TREATMENT OF DISORDERS RELATED TO EPILEPTIC SEIZURES
UndeterminedMA43532A
Owner:ADAMAS PHARMA INC
Benzimidazole derivatives as bromodomaine inhibitors
UndeterminedMA41778A
Owner:GLAXOSMITHKLINE INTPROP DEV LTD
ANTI-LIF ANTIBODIES AND THEIR GALENICAL FORMS
UndeterminedMA52021A
Owner:INSTITUCIO CATALANA DE RECERCA I ESTUDIS AVANCATS (ICREA) +2
C-3 and C-17 modified triterpenoids used as HIV-1 inhibitors
ActiveMA43960A
Owner:VIIV HEALTHCARE UK (NO 5) LTD
Excipients for reducing the viscosity of antibody formulations and formulation compositions
UndeterminedMA48461A
Owner:AMGEN INC
METHOD FOR PRODUCING A PRE-COATED STEEL SHEET AND ASSOCIATED SHEET
ActiveMA50832A
Owner:ARCELORMITTAL SA
METHODS FOR MANUFACTURED PAPER PRODUCTS USING A MULTILAYER CREPPING BELT AND PAPER PRODUCTS MANUFACTURED USING A MULTILAYER CREPPING BELT
UndeterminedMA40758A
Owner:GEORGIA PACIFIC CONSUMER PRODS LP
NEW PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS
UndeterminedMA71753A
Owner:CYCLERION THERAPEUTICS INC
PYRIDAZINE THERAPEUTIC COMPOUNDS AND THEIR USES
UndeterminedMA41598A
Owner:CONSTELLATION PHARMA INC +1
SKI BOOT OR OFF-PISTE SKI BOOT EQUIPPED WITH ADVANCED BINDING SYSTEMS
UndeterminedMA39872A
Owner:OBER ALP
PYRIMIDINE COMPOUNDS USED AS JAK KINASE INHIBITORS
InactiveMA49956A
Owner:THERAVANCE BIOPHARMA R&D IP LLC
Pharmaceutical compositions and their uses against lysosomal storage diseases
ActiveMA45615A
Owner:INTRABIO LTD
COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF OXALATE-RELATED DISEASES
UndeterminedMA45226A
Owner:OXTHERA INTPROP
USE OF COENZYME Q10 FORMULATIONS IN THE TREATMENT AND PREVENTION OF EPIDERMOLYSIS BULLISA
UndeterminedMA52274A
Owner:BERG LLC
DATA PROCESSING METHOD, SYSTEM, APPARATUS, INFORMATION STORAGE MEDIUM AND DEVICE
UndeterminedMA51867A
Owner:TENCENT TECHNOLOGY (SHENZHEN) CO LTD
DEVICES AND METHODS FOR REGULATING THE FLOW OF OPHTHALMIC FORMULATIONS
UndeterminedMA55547A
Owner:TEARCLEAR CORP
REINFORCEMENT STRUCTURE FOR THE REAR SIDE OF A VEHICLE COMPARTMENT
Owner:ARCELORMITTAL SA
Pharmaceutical compositions for the treatment of cystic fibrosis
UndeterminedMA51739A
Owner:VERTEX PHARMACEUTICALS INC
METHOD FOR JOINTING OR SEPARATING TWO PARTS OF A PLASTIC INJECTION MOLD
UndeterminedMA49388A
Owner:PSA AUTOMOBILES SA
TEAR-OPEN PACKAGING FOR SINGLE-DOSE, SEALED, AND ASSOCIATED PRODUCTION PROCESS
UndeterminedMA51547A
Owner:V SHAPES SRL
FORMULATION COMPRISING GLYCOPYRROLATE, PROCESS AND APPARATUS
Owner:VECTURA LTD
Compositions of crystallized hydrophobic compounds and their processes of preparation and use
UndeterminedMA44611A
Owner:MASSACHUSETTS INST OF TECH
FRUIT HARVESTING DEVICE FEATURING AN ADVANCED ROBOT ARM
UndeterminedMA45710A
Owner:OCTINION ROBOTICS BV
DYNAMIC PROCESS AND ENVIRONMENTAL MONITORING SYSTEM
UndeterminedMA45254A
Owner:DE MASI IVANO TOMMASO IPPAZIO +1
POTASSIUM BINDING AGENTS FOR USE IN PATIENTS UNDER HEMODIALYSIS
UndeterminedMA55287A
Owner:ASTRAZENECA AB
MACITENTAN INTENDED FOR USE IN THE TREATMENT OF PORTOPULMONARY HYPERTENSION
UndeterminedMA55507A
Owner:ACTELION PHARMACEUTICALS LTD
MIRIKIZUMAB INTENDED FOR USE IN A TREATMENT PROCESS FOR CROHN'S DISEASE
UndeterminedMA55756A
Owner:ELI LILLY & CO
MULTIFUNCTIONAL WIND / HYDROW TURBINES AND THEIR COLLECTION FOR MULTIPLE APPLICATIONS AND USES
UndeterminedMA43997A
Owner:TECHSAFE GLOBAL
COMBINATION THERAPIES AND PATIENT STRATIFICATION WITH ANTI-EGFR / C-MET BISPECIFIC ANTIBODIES
UndeterminedMA55089A
Owner:JANSSEN BIOTECH INC
IDENTIFICATION OF CYTOSIN MODIFICATIONS BY BASIC, BISULFITE-FREE RESOLUTION
UndeterminedMA51633A
Owner:LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
METHODS OF TREATING A GLIOBLASTOMA WITH RILUZOLE PROMEDICINAL PRODUCTS
UndeterminedMA71260A
Owner:BIOHAVEN THERAPEUTICS LTD
MODIFIED MRNA ENCODED BY GLUCOSE-6-PHOSPHATASE AND RELATED USES
UndeterminedMA49684A
Owner:MODERNATX INC
VEHICLE WITH AN ACCESS MANAGEMENT SYSTEM AND METHOD FOR AUTHORIZING ACCESS TO A VEHICLE
ActiveMA52110A
Owner:PSA AUTOMOBILES SA
PRESSURE REGULATION DEVICE FOR PRESSURE CONTAINERS
UndeterminedMA55303A
Owner:SILAMPOS SOC IND DE LOUCA METALICA CAMPOS
IMPROVEMENTS MADE TO DISPLAY REFRIGERATORS AND FREEZERS
UndeterminedMA55601A
Owner:AEROFOIL ENERGY LTD
PHOSPHINE OXIDE ALKYL AMIDE-SUPPLEMENTED HETEROARYL COMPOUNDS AS MODULATORS OF IL-12, IL-23 AND / OR IFN ALPHA RESPONSES
UndeterminedMA48602A
Owner:BRISTOL MYERS SQUIBB CO
APPARATUS AND METHOD FOR GUIDING AND SUBSEQUENTLY POSITIONING AXES OF A NUMERICALLY CONTROLLED MACHINE
ActiveMA41428Apreserve functionalitypreserve operating
Owner:ZERAS SRL
METHOD AND DEVICE FOR THE MANUFACTURE OF CRUSHED SAND OR ARTIFICIALLY GROWN SAND BY THERMAL TREATMENT WITH THE USE OF FINE SAND AND / OR ROLLED SAND AS STARTING MATERIAL
ActiveMA39967A
Owner:INNOVATIVE SAND GMBH
MAT2A HETEROBICYCLIC AZA INHIBITORS AND METHODS OF USE FOR CANCER TREATMENT
ActiveMA54608A
Owner:LES LAB SERVIER SA
SYSTEM AND METHOD FOR EVALUATING THE COGNITIVE STATES AND MOOD OF A REAL-WORLD USER BASED ON VIRTUAL-WORLD ACTIVITY
UndeterminedMA45180A
Owner:JANSSEN PHARMA NV
A DEVICE TO FACILITATE THE ADMINISTRATION OF MEDICATION TO THE LUNGS VIA A CATHETER
UndeterminedMA46605A
Owner:CHIESI FARMACEUTICI SPA
Blood-Breath-Penetrating Dopamine-Hydroxylase Inhibitors
UndeterminedMA46273A
Owner:BIAL PORTELA & CA SA
Substituted indole derivatives used as dengue virus replication inhibitors
UndeterminedMA44502A
Owner:JANSSEN PHARMACEUTICALS INC +1
COMBINATION COMPRISING PALBOCICLIB AND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID AND ITS USE FOR THE TREATMENT OF CANCER
InactiveMA49673A
Owner:SANOFI SA(FR)
METHOD FOR CONTROLLING A NETWORK OF DYNAMIC ARROWING DEVICES AND GUIDANCE SYSTEM CONFIGURED TO IMPLEMENT SUCH A METHOD
UndeterminedMA40009A
Owner:CHARVET IND
Pre-printed surface for handwriting, comprising a pre-printed graphical representation of the passing of a period of time, and associated computer program
UndeterminedMA40353A
Owner:HOLDHAM
Sofa, armchair or similar furniture item in kit form and assembly instructions for such item
UndeterminedMA51892A
Owner:NARDI SPA
PROCESS FOR PREPARATION OF GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
UndeterminedMA40517A
Owner:ARVEN ILAC SANAYI VE TICARET
COMPOSITIONS AND METHODS OF TREATMENT OF TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS
UndeterminedMA50267A
Owner:ALNYLAM PHARMACEUTICALS INC
Substituted azacycles used as positive allosteric modulators of the muscarinic receptor M1
UndeterminedMA50806A
Owner:SUVEN LIFE SCI LTD
CONNECTOR WITH A LOCKING PART AND METHOD FOR INSTALLING THE CONNECTOR
UndeterminedMA41371A
Owner:ZODIAC INTERCONNECT UK
OVERMOLDING METHOD ON A PLASTIC INSERT AND AUTOMOTIVE PART OBTAINED BY THIS METHOD
InactiveMA41023A
Owner:COMPAGNIE PLASTIC OMNIUM SA
MODULAR BEVERAGE HOLDER FOR ACTIVELY COOLING DRINKS AND ITS MANUFACTURING PROCESS
UndeterminedMA46775A
Owner:LEGACY US LLC
SPRAY-DRIED FORMULATION OF A TRPC5 PYRIDAZINONE INHIBITOR
UndeterminedMA55621A
Owner:GOLDFINCH BIO INC
METHOD FOR LINKING, TRANSPORTING, ACTIVATING THE REACTION, CONVERSING, STORING AND RELEASING SOLUBLE GASES IN WATER
UndeterminedMA71579A
Owner:DIETZ ULRICH
ENHANCING IMMUNE ACTIVITY THROUGH MODULATION OF POST-CELLULAR SIGNALING FACTORS
UndeterminedMA52889A
Owner:FLAGSHIP PIONEERING INNOVATIONS V INC
METHOD FOR SCREENING A MUTANT IN A POPULATION OF ORGANISMS BY APPLYING A GROUPING AND DIVISION APPROACH
UndeterminedMA45531A
Owner:CARLSBERG BREWERIES AS
METHOD FOR ACTUATING ACTIVE-MATRICE DISPLAYS, CORRESPONDING CONTROL DEVICE, AND COMPUTER PROGRAM PRODUCT
UndeterminedMA71608A
Owner:PENNY PIXEL INC
FGFR2 inhibitors used in the treatment of cholangiocarcinoma
UndeterminedMA49248A
Owner:JANSSEN PHARMA NV
Anti-PD-1 antibodies, actionable anti-PD-1 antibodies, and their methods of use
UndeterminedMA42447A
Owner:CYTOMX THERAPEUTICS INC
METHOD FOR DETECTING AND RECOGNIZING WIDE-RANGE, HIGH-DENSITY VISUAL MARKERS
UndeterminedMA47132A
Owner:UNIV DE ALICANTE
PROCESSES AND COMPOSITIONS FOR THE TREATMENT OF CANCER
Owner:MEMORIAL SLOAN KETTERING CANCER CENT
Post-transcribernal regulatory elements of modified hepatitis
UndeterminedMA41346A
Owner:JUNO THERAPEUTICS INC
Closed-ended DNA vectors (CEDNA) for the insertion of transgenes at the level of Genomic Safe Havens (GSH) in human and mouse genomes
UndeterminedMA52116A
Owner:GENERATION BIO CO
PHARMACEUTICAL COMPOSITION COMPRISING AN HMG-CoA REDUCTASE INHIBITOR AND AN ACE INHIBITOR
UndeterminedMA42696A
Owner:LES LAB SERVIER SA
Pharmaceutical formulations comprising high-purity cangrelor and their methods of preparation and use
UndeterminedMA41326A
Owner:CHIESI FARMACEUTICI SPA
USE OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS
UndeterminedMA51413A
Owner:CHIESI FARMACEUTICI SPA
METHODS AND INTERMEDIATES FOR THE PREPARATION OF C5AR ANTAGONISTS
UndeterminedMA52308A
Owner:CHEMOCENTRYX INC
METHOD FOR MANUFACTURED STABLE BACTERIAL EXTRACTS AND THEIR USE AS PHARMACEUTICAL PRODUCTS
ActiveMA55291A
Owner:OM PHARMA SA
Styling and cleaning devices for needle-free vasculature access connectors
UndeterminedMA55036A
Owner:CLEANSITE MEDICAL INC
METHOD FOR MANUFACTURING A COMPOSITE GLASS WITH A FUNCTIONAL ELEMENT
UndeterminedMA46682A
Owner:SAINT GOBAIN VITRAGE SA
INJECTION HEAD FOR A FLUID SUBSTANCE ALLOWING CONTROL OF THE INJECTION SITE BEFORE INJECTION OF THE FLUID SUBSTANCE, AND A SYRINGE COMPRISING SUCH A HEAD
UndeterminedMA51834A
Owner:ADDA JEAN MARC
COMPOSITIONS COMPRISING PARABACTEROID BACTERIAL STRAINS FOR CANCER TREATMENT
UndeterminedMA54161A
Owner:4D PHARMA RES LTD
ENAMELED SUBSTRATE FORMING A PROJECTION SCREEN, AND ITS MANUFACTURE
UndeterminedMA53313A
Owner:SAINT GOBAIN VITRAGE SA
HARQ TIMER ADJUSTMENT FOR PDSCH WITH PDSCH TIMER INDICATOR IN HARQ WAITING
UndeterminedMA55688A
Owner:TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)
HETEROARYLSULFONYL SUBSTITUTION PYRIDINES AND THEIR USE IN CANCER TREATMENT
UndeterminedMA47451A
Owner:OBLIQUE THERAPEUTICS AB
COMBINATIONS OF PD-1 ANTAGONISTS AND STING BENZO[B]AGONISTS
UndeterminedMA49773A
Owner:MERCK SHARP & DOHME CORP
Rogaratinib hydrochloride monohydrate and associated solid states
UndeterminedMA54856A
Owner:BAYER PHARMA AG +1
STEEL SHEET OF VARIABLE THICKNESS HAVING A REDUCED RISK OF DELAYED FAILURE AFTER HARDENING BY PRESS DIP AND METHOD FOR THEIR MANUFACTURE
UndeterminedMA71688A
Owner:ARCELORMITTAL SA
METHODS AND COMPOSITIONS FOR TREATING AGING-RELATED DISORDERS BY MEANS OF CCR3 INHIBITORS
UndeterminedMA53743A
Owner:ALKAHEST INC
COMPOSITE DISC EQUIPPED WITH A FUNCTIONAL AND LIGHTING ELEMENT
UndeterminedMA52263A
Owner:SAINT GOBAIN VITRAGE SA
LIPOSOMAL FORMULATION FOR JOINT LUBRICATION
Owner:MOEBIUS MEDICAL LTD
ANTIGEN DISCOVERY FOR T-LYMPHOCYTE RECEPTORS ISOLATED FROM PATIENT TUMORS RECOGNIZING WILD-TYPE ANTIGENS AND POTENT PEPTIDE MIMOTOPES
UndeterminedMA49012A
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
SELF-SUPPORTING WATERPROOFING POLYMER SYNTHETIC SHEET WITH SELF-REPAIRING CAPACITY
UndeterminedMA43208A
Owner:ATARFIL
AIR CONDITIONING SYSTEM FOR A BUILDING INCLUDING A CONTROL BOX CAPABLE OF RECEIVING INSTRUCTIONS TO REDUCE ELECTRICAL CONSUMPTION FROM AN EXTERNAL AGGREGATOR
UndeterminedMA46991A
Owner:SOLUTIONS ENERGIES NOUV RENOUVELABLES